Antidepressants in Child and Adolescent Psychiatry.
- Author:
Su Jin YANG
1
;
Jae Min KIM
;
Jin Sang YOON
;
Sun Young KIM
Author Information
1. Department of Psychiatry, Chonnam National University Hospital, Gwangju, Korea. sjyang@chonnam.ac.kr
- Publication Type:Review
- Keywords:
Antidepressant;
Child;
Adolescent;
Selective Serotonin Reuptake Inhibitors
- MeSH:
Adolescent;
Adolescent Psychiatry;
Antidepressive Agents;
Child;
Humans;
Psychotropic Drugs;
Risk Assessment;
Serotonin;
Serotonin Uptake Inhibitors;
Suicidal Ideation;
United States Food and Drug Administration
- From:Journal of the Korean Academy of Child and Adolescent Psychiatry
2008;19(2):83-88
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Antidepressants, in particular selective serotonin reuptake inhibitors(SSRIs), are one of the most commonly used classes of psychotropic drugs for treating children and adolescents. The US Food and Drug Administration has issued a black box warning concerning the increased risks of suicidal ideation and behavior associated with antidepressant treatment in children and adolescents. The aim of this review is to assess the risks and benefits of antidepressants in the treatment of child and adolescent psychiatric disorders.
